Matthew Strobeck

Quidel has appointed Matthew Strobeck, managing partner of Birchview Capital, to the company's board of directors after increasing the size of its board from seven to eight members. Strobeck was previously with Westfield Capital Management and currently serves on the boards of Accelerate Diagnostics and Biodesix.